Skip to content
Archive

Kolinpharma® announces its editorial collaboration with Edit Symposia

KOLINPHARMA® announces its collaboration with Edit Symposia, a prestigious series of continuing education publications for gynaecologists throughout Italy.

Edit Symposia, distributed by the publisher Editeam, a point of reference for gynaecology and obstetrics for more than thirty years, offers innovative and multidisciplinary scientific content that is essential for modern clinical practice.

This collaboration aims to support gynaecology professionals with continuing education tools of high scientific value, covering crucial topics ranging from pathophysiology to diagnostics, from pharmacology to prevention. All with a specific focus on the new emerging care needs arising from demographic and epidemiological changes and from the lifestyles of the population.

Through this partnership Kolinpharma®, which for more than 10 years has stood beside Gynaecologists with its unique and innovative range of patented nutraceuticals holding multiple certifications in the area of “women’s wellbeing”, strengthens its commitment to promoting an inter- and multidisciplinary approach, encouraging the spread of up-to-date knowledge that can improve the quality of specialist care across the country. This collaboration also strengthens the omnichannel communication project, in addition to medical-scientific information, with the aim of offering the best support to specialist doctors in managing their clinical practice.

On the occasion of the National Women’s Health Day, KOLINPHARMA® confirms its commitment to gender medicine, always beside specialists and women, with initiatives dedicated to women’s wellbeing and solutions formulated to accompany every stage of their lives.

Our presence in Edit Symposia

More news

  1. Once again this year Kolinpharma® is recognised at the Credit Awards: a further example of corporate excellence in financial management
  2. Kolinpharma® receives a new award, the “America Innovazione” prize, from the Fondazione Italia USA
  3. From confusion to clarity: why Italy must set specific guidelines for nutraceuticals. The proposal of Kolinpharma®.
Archive